Clozapine-induced pericardial effusion

Journal of Clinical Psychopharmacology

Volumn 28, Issue 4, 2008, Pages 455-456

  Dauner, Daniel G ^a   Deremer, Christina E ^a   Haburchak, David ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; PREDNISONE; VALPROIC ACID; NEUROLEPTIC AGENT;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HUMAN; IMAGE ANALYSIS; INFLAMMATION; LETTER; LEUKOCYTOSIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM; TACHYCARDIA; CHEMICALLY INDUCED DISORDER; ECHOCARDIOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; PERICARDIAL EFFUSION; SCHIZOPHRENIA;

EID: 54449085121     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31817d86f0     Document Type: Letter

References (4)

1. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354:1841-1845.
2. Bhatti MA, Zander J, Reeve E. Clozapine- induced pericarditis, pericardial tamponade, polyserositis, and rash. J Clin Psychiatry. 2005;66(11):1490-1491.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
4. Catalano G, Catalano MC, Frankel Wetter RL. Clozapine induced polyserositis. Clin Neuro-pharmacol. 1997;20(4):352-356.